Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.

ABSTRACT: In both preclinical animal studies and human clinical trials, adult females tend to develop greater adaptive immune responses than males following receipt of either viral or bacterial vaccines. While there is currently no approved malaria vaccine, several anti-sporozoite vaccines, including RTS,S/AS01 and attenuated sporozoite vaccines, are in development, but the impact of sex and age on their efficacy remains undefined. To examine sex differences in the efficacy of anti-sporozoite stage malaria vaccination, adult (10 weeks of age) or juvenile (11 days of age) male and female C3H mice were twice vaccinated with irradiated transgenic Plasmodium berghei sporozoites expressing the P. falciparum circumsporozoite (CSP) protein and 45 days post boost vaccination, mice were challenged with trans

SUBMITTER: Vom Steeg LG 

PROVIDER: S-EPMC7862922 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature